Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive sertraline for drug-resistant temporal lobe epilepsy
IRCT20200517047483N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sertraline in temporal lobe epilepsy (TLE), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Seizure count. Started Sep 2022; status: completed.
02
Drugs
sertraline
03
Conditions
temporal lobe epilepsy (TLE)
Beyond the preview
Go deeper on IRCT20200517047483N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200517047483N1.